Market revenue in 2023 | USD 8,429.6 million |
Market revenue in 2030 | USD 11,370.4 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Siemens Healthineers AG ADR, Roche Holding AG, Horiba Ltd, ElitechGroup, QuidelOrtho Corp, Randox, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical chemistry analyzers market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 44.62% in 2023. Horizon Databook has segmented the North America clinical chemistry analyzers market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America clinical chemistry analyzers market , including forecasts for subscribers. This continent databook contains high-level insights into North America clinical chemistry analyzers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account